Stocksigma LogoStocksigma Logo

Mirae Asset Mutual Fund Acquires 5.44% Stake in Symbiotec Pharmalab

On 1st Sep'26, Mirae Asset Mutual Fund acquired 3,497,420 equity shares of Symbiotec Pharmalab Ltd via an open market transaction, representing a 5.44%

Mirae Asset Mutual Fund Acquires 5.44% Stake in Symbiotec Pharmalab

Symbiotec Pharmalab Ltd 路 Acquisition/ Disposal of Shares 路 02 Sept 2026, 10:35 pm

Mirae Asset Mutual Fund Acquires 5.44% Stake in Symbiotec Pharmalab On 1st Sep'26, Mirae Asset Mutual Fund acquired 3,497,420 equity shares of Symbiotec Pharmalab Ltd via an open market transaction, representing a 5.44% stake. Prior to this purchase, the fund held 498,019 shares, or a 0.78% stake. Following the transaction, Mirae Asset's total holding in Symbiotec Pharmalab significantly increased to 3,995,439 shares, equating to a 6.22% total voting capital stake (6.21% on a fully diluted basis). This block purchase effectively triggers SEBI disclosure requirements for crossing the key 5% ownership threshold.

Original exchange filing (PDF)

More announcements from Symbiotec Pharmalab Ltd

All Symbiotec Pharmalab Ltd announcements